Citius Pharmaceuticals, Inc. (CTXR) vs Sintx Technologies, Inc. (SINT)
A side-by-side comparison of Citius Pharmaceuticals, Inc. and Sintx Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTXR
Citius Pharmaceuticals, Inc.
$0.50HealthcareDelayed quote: Oct 6, 2026, 1:47 PM EDT
SINT
Sintx Technologies, Inc.
$2.19HealthcareDelayed quote: Oct 6, 2026, 1:45 PM EDT
Total return — CTXR vs SINT
growth of $100 · dividends reinvested · last 10yCTXR -99.9% (-51.0%/yr)SINT -100.0% (-77.5%/yr)CTXR compounded faster over this window
Log scale — wide-divergence pair
CTXR SINT
CTXR vs SINT: by the numbers
- •SINT is the larger company ($14M vs $14M market cap).
- •Both run net losses; CTXR's is the smaller (-651.27% vs -1303.40% net margin).
Metrics side by side
Valuation
| Metric | CTXR | SINT |
|---|---|---|
| P/S ratio | 1.91 | 10.08 |
| P/B ratio | 0.20 | 2.88 |
Profitability
| Metric | CTXR | SINT |
|---|---|---|
| Gross margin | 0.00% | -19.74% |
| Operating margin | 0.00% | -1053.14% |
| Net margin | -651.27% | -1303.40% |
| ROE | -69.47% | -372.67% |
| ROIC | -67.62% | -157.90% |
Growth (annualized)
| Metric | CTXR | SINT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 29.18% |
| Total return CAGR (5Y) | -60.04% | N/A |
Go deeper
Dig into the metrics
Citius Pharmaceuticals ROESintx Technologies ROECitius Pharmaceuticals operating marginSintx Technologies operating marginCitius Pharmaceuticals revenue growthSintx Technologies revenue growthCitius Pharmaceuticals free cash flowSintx Technologies free cash flow
Citius Pharmaceuticals & Sintx Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.